Comparative Effectiveness of Intralesional Therapy for Peyronie’s Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis

Giorgio Ivan Russo, MD, PhD; Giovanni Cacciamani, MD; Andrea Cocci, MD; Thomas M. Kessler, MD; Giuseppe Morgia, MD; Ege Can Serefoglu, MD, FECSM; Maarten Albersen, MD, PhD; Paolo Verze, MD, PhD, on behalf of EAU-YAU Men’s Health Working Group

FIRST PUBLISHED: January 25, 2019 – The Journal of Sexual Medicine

DOI: https://doi.org/10.1016/j.jsxm.2018.12.011

Many men feel anxious and distressed about their penis size and seek medical procedures to increase it. Most men in this situation already have a normal-sized penis (The average length of an erect penis is 13.1 centimeters; the average girth is 11.65 centimeters.)

Penile Prosthesis Reservoir Removal: Surgical Description and Patient Outcomes

Jonathan Clavell-Hernández, MD; Samuel G. Aly, MD; Run Wang, MD; Hossein Sadeghi-Nejad, MD

FIRST PUBLISHED: December 12, 2018 – The Journal of Sexual Medicine

DOI:https://doi.org/10.1016/j.jsxm.2018.11.002

The first of the two recent studies reporting risks with testosterone prescriptions, published in the Journal of the American Medical Association by Vigen et al (1), was a retrospective analysis of a dataset of 8709 men in the VA health system who had undergone coronary angiography. Among men with testosterone concentrations less than 300ng/dl, the authors reported an increased rate of heart attacks, strokes, and deaths in men who received a testosterone prescription compared with men who did not.

Pharmacologic treatment of premature ejaculation represents a new approach to the treatment of PE and a radical departure from the psychosexual model of treatment. There have been many papers discussing this topic. I chose to write a clinical paper, in the form of Questions and Answers, which is an innovative way of writing an article (with several citations) to help clinicians in the management of premature ejaculation.